Neuroscience Update 2020 | Insights & Innovations

Join us for a half-day CME opportunity presenting the latest clinical insights & innovations in a wide spectrum of neurological disorders. Within this all-encompassing conference you'll learn about the latest discoveries in recognizing and managing multiple sclerosis, pituitary tumors, alternatives to opioids, migraines, cognitive disorders and an objective review of the effectiveness and safety of cannabis. 

2020 Event Details 

Registration is now closed

April 18, 2020

7:30 a.m. to 1:30 p.m.

Hyatt Regency Sacramento
1209 L Street
Sacramento, CA 95814  

7:30 a.m. Registration and networking
8:00 a.m. Welcome, Featured Presentations
1:30 p.m. Closing Remarks/Adjourn

Our featured presentations will include:

Multiple Sclerosis

John Schafer, MD


Pituitary Tumors

Michael Chan, MD


Alternatives to Opioids with Back Pain

Alicia Kurtz, MD

Migraines & Headaches

Marc Lenaerts, MD


Cognitive Disorders

Ashkan Javaheri, MD


Medical Marijuana - The Critical Role of Health Professionals

Allen C. Bowling, MD, PhD


"After this presentation, participants should be able to":

  • Order appropriate tests and make referrals to confirm the diagnosis and select best treatment options for patients
  • Determine the proper write-up for a pituitary mass
  • Be equipped with the language and phrases needed to successfully discuss the selection of non-opioid medications in the treatment of mild to moderate or chronic pain
  • Apply evidence based therapeutic principles to improve migraine treatment in patients
  • Recognize common clinical presentations of cognitive disorders in order to offer early access to diagnosis and treatment
  • Describe therapeutic effects and possible side effects of cannabis to patients


As a provider accredited by the California Medical Association, we must ensure balance, independence, objectivity and scientific rigor in all of our sponsored educational activities. We at Dignity Health Sacramento Office of Continuing Medical Education adhere to the ACCME Standards for Commercial Support.

The following speakers have indicated an affiliation with organizations which have interests related to the content of this program. Per Dignity Health Sacramento CME office policy, these potential conflicts of interest have been resolved. 

  • Dr. Bowling is a speaker and primary investigator for EMD-Serano. A speaker for Genentech, Genzyme, and Novartis and is a consultant for Celgene and Alexion
  • Dr. Schafer is apart  of the speakers bureau and a consultant panel for Biogen, Genentech, Genzyme (Sanofi), TEVA Neuroscience, EMD Serono, Celgen. I was an investigator in clinical trials sponsored by Genentech and Novartis.

The potential conflicts of interest have been resolved and determined the presentations are without bias.

  • Dr. Chan, Dr. Javaheri, Dr. Kurtz, Dr. Lenaerts, Dignity Health Sacramento CME committee members, and all other planners involved and able to influence the content of this presentation have reported no relevant financial relationships/interest with any commercial entities that may have ties to this presentation.

Accreditation Statement:

Dignity Health Sacramento is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. 

Dignity Health Sacramento designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.